In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles

Journal of Controlled Release

Volumn 112, Issue 1, 2006, Pages 26-34

  Reddy, Sai T ^a   Rehor, Annemie ^a   Schmoekel, Hugo G ^a,b   Hubbell, Jeffrey A ^a   Swartz, Melody A ^a  

^a EPFL   (Switzerland)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antigen presenting cells; Immunotherapy; Macrophages; Vaccines

Indexed keywords

ANTIGEN-PRESENTING CELLS; IMMUNOTHERAPY; MACROPHAGES;

ANTIGENS; CROSSLINKING; IMMUNOLOGY; NANOSTRUCTURED MATERIALS; ORGANIC POLYMERS;

CELLS;

LIGAND; MACROGOL; NANOPARTICLE; POLY(PROPYLENE SULFIDE); POLYPROPYLENE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INFILTRATION; CROSS LINKING; DENDRITIC CELL; DRUG DEGRADATION; DRUG STABILITY; FEMALE; HYDROPHILICITY; HYDROPHOBICITY; IN VIVO STUDY; INJECTION SITE; LYMPH NODE; LYMPH VESSEL; MOUSE; NONHUMAN; OXIDATION; PRIORITY JOURNAL;

ANIMALS; DENDRITIC CELLS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCEIN ANGIOGRAPHY; INJECTIONS, INTRADERMAL; LYMPH NODES; MICE; MICE, INBRED BALB C; NANOPARTICLES; PHAGOCYTOSIS; POLYETHYLENE GLYCOLS; SULFIDES; TIME FACTORS;

EID: 33646480406     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2006.01.006     Document Type: Article

References (57)

1. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 6673 (1998) 245-252
2. Cyster J.G. Chemokines-chemokines and cell migration in secondary lymphoid organs. Science 286 5447 (1999) 2098-2102
3. Randolph G.J., Angeli V., and Swartz M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5 (2005) 617-628
4. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., and Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8(+) T cell tolerance. J. Exp. Med. 196 12 (2002) 1627-1638
5. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., Brimnes M.K., Moltedo B., Moran T.M., and Steinman R.M. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. 199 6 (2004) 815-824
6. Jilek S., Merckle H.P., and Walter E. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendrite cells. Adv. Drug Deliv. Res. 57 3 (2005) 377-390
7. Elamanchili P., Diwan M., Cao M., and Samuel J. Characterization of poly(d,l-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells. Vaccine 22 19 (2004) 2406-2412
8. Faraasen S., Voros J., Csucs G., Textor M., Merkle H.P., and Walter E. Ligand-specific targeting of microspheres to phagocytes by surface modification with poly(l-lysine)-grafted poly(ethylene glycol) conjugate. Pharm. Res. 20 2 (2003) 237-246
9. Kwon Y.J., James E., Shastri N., and Frechet J.M. In vivo targeting of dendritic cells for activation of cellular immunity using vaccine carriers based on pH-responsive microparticles. Proc. Natl. Acad. Sci. U. S. A. 102 51 (2005) 18264-18268
10. Kwon Y.J., Standley S.M., Goh S.L., and Frechet J.M. Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles. J. Control. Release 105 3 (2005) 199-212
11. Kwon Y.J., Standley S.M., Goodwin A.P., Gillies E.R., and Frechet J.M. Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses. Mol. Pharmacol. 2 1 (2005) 83-91
12. van Broekhoven C.L., Parish C.R., Demangel C., Britton W.J., and Altin J.G. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res. 64 12 (2004) 4357-4365
13. Wang C., Ge Q., Ting D., Nguyen D., Shen H.R., Chen J.Z., Eisen H.N., Heller J., Langer R., and Putnam D. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat. Mater 3 3 (2004) 190-196
14. Wang R.F., and Wang H.Y. Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells. Nat. Biotechnol. 20 2 (2002) 149-154
15. Wilson N.S., El-Sukkari D., Belz G.T., Smith C.M., Steptoe R.J., Heath W.R., Shortman K., and Villadangos J.A. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102 6 (2003) 2187-2194
16. Sixt M., Kanazawa N., Seig M., Samson T., Roos G., Reinhardt D.P., Pabst R., Lutz M.B., and Sorokin L. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity 22 1 (2005) 19-29
17. Pack D.W. Timing is everything. Nat. Mater. 3 3 (2004) 133-134
18. Probst H.C., Lagnel J., Kollias G., and van den Broek M. Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. Immunity 18 5 (2003) 713-720
19. Copland M.J., Baird M.A., Rades T., McKenzie J.L., Becker B., Reck F., Tyler P.C., and Davies N.M. Liposomal delivery of antigen to human dendritic cells. Vaccine 21 9-10 (2003) 883-890
20. Swartz M.A. The physiology of the lymphatic system. Adv. Drug Deliv. Rev. 50 1-2 (2001) 3-20
21. Porter C.J.H. Drug delivery to the lymphatic system. Crit. Rev. Ther. Drug Carr. Syst. 14 4 (1997) 333-393
22. Porter C.J.H., and Charman S.A. Lymphatic transport of proteins after subcutaneous administration. J. Pharm. Sci. 89 3 (2000) 297-310
23. Papisov M., and Weissleder R. Drug delivery to lymphatic tissue. Crit. Rev. Ther. Drug Carr. Syst. 13 1-2 (1996) 57-84
24. Oussoren C., Zuidema J., Crommelin D.J.A., and Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: 2. Influence of liposomal size, lipid composition and lipid dose. Biochim. Biophys. Acta, Biomembr. 1328 2 (1997) 261-272
25. Hawley A.E., Davis S.S., and Illum L. Targeting of colloids to lymph-nodes-influence of lymphatic physiology and colloidal characteristics. Adv. Drug Deliv. Rev. 17 1 (1995) 129-148
26. Allen T.M., Hansen C.B., and Guo L.S.S. Subcutaneous administration of liposomes-a comparison with the intravenous and intraperitoneal routes of injection. Biochim. Biophys. Acta 1150 1 (1993) 9-16
27. Moghimi S.M. Modulation of lymphatic distribution of subcutaneously injected poloxamer 407-coated nanospheres: the effect of the ethylene oxide chain configuration. FEBS Lett. 545 2-3 (2003) 241-244
28. Moghimi S.M., and Bonnemain B. Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. Adv. Drug Deliv. Rev. 37 1-3 (1999) 295-312
29. Nishioka Y., and Yoshino H. Lymphatic targeting with nanoparticulate system. Adv. Drug Deliv. Rev. 47 1 (2001) 55-64
30. Oussoren C., and Storm G. Liposomes to target the lymphatics by subcutaneous administration. Adv. Drug Deliv. Rev. 50 (2001) 143-156
31. Oussoren C., and Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: 3. Influence of surface modification with poly(ethyleneglycol). Pharm. Res. 14 10 (1997) 1479-1484
32. Moghimi S.M., Hawley A.E., Christy N.M., Gray T., Illum L., and Davis S.S. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph-nodes. FEBS Lett. 344 1 (1994) 25-30
33. Hawley A.E., Illum L., and Davis S.S. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm. Res. 14 5 (1997) 657-661
34. Hawley A.E., Illum L., and Davis S.S. Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers. FEBS Lett. 400 3 (1997) 319-323
35. Illum L., Church A.E., Butterworth M.D., Arien A., Whetstone J., and Davis S.S. Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration. Pharm. Res. 18 5 (2001) 640-645
36. Oussoren C., Velinova M., Scherphof G., van der Want J.J., van Rooijen N., and Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection: IV. Fate of liposomes in regional lymph nodes. Biochim. Biophys. Acta, Biomembr. 1370 2 (1998) 259-272
37. Oussoren C., and Storm G. Role of macrophages in the localisation of liposomes in lymph nodes after subcutaneous administration. Int. J. Pharm. 183 1 (1999) 37-41
38. Rehor A., Hubbell J.A., and Tirelli N. Oxidation-sensitive polymeric nanoparticles. Langmuir 21 1 (2005) 411-417
39. Rehor A., Tirelli N., and Hubbell J.A. A new living emulsion polymerization mechanism: episulfide anionic polymerization. Macromolecules 35 23 (2002) 8688-8693
40. Napoli A., Valentini M., Tirelli N., Muller M., and Hubbell J.A. Oxidation-responsive polymeric vesicles. Nat. Mater. 3 3 (2004) 183-189
41. Olszewski W.L. Lymph Stasis Pathophysiology, Diagnosis and Treatment (1991), CRC Press, Boca Raton
42. Berk D.A., Swartz M.A., Leu A.J., and Jain R.K. Transport in lymphatic capillaries: 2. Microscopic velocity measurement with fluorescence photobleaching. Am. J. Physiol.: Heart Circ. Physiol. 39 1 (1996) H330-H337
43. Swartz M.A., Berk D.A., and Jain R.K. Transport in lymphatic capillaries: 1. Macroscopic measurements using residence time distribution theory. Am. J. Physiol.: Heart Circ. Physiol. 39 1 (1996) H324-H329
44. Swartz M.A., Kaipainen A., Netti P.A., Brekken C., Boucher Y., Grodzinsky A.J., and Jain R.K. Mechanics of interstitial-lymphatic fluid transport: theoretical foundation and experimental validation. J. Biomech. 32 12 (1999) 1297-1307
45. Angeli V., Llodra J., Rong J.X., Satoh K., Ishii S., Shimizu T., Fisher E.A., and Randolph G.J. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21 4 (2004) 561-574
46. da Silva R.P., and Gordon S. Phagocytosis stimulates alternative glycosylation of macrosialin (mouse CD68), a macrophage-specific endosomal protein. Biochem. J. 338 Pt 3 (1999) 687-694
47. Holness C.L., da Silva R.P., Fawcett J., Gordon S., and Simmons D.L. Macrosialin, a mouse macrophage-restricted glycoprotein, is a member of the lamp/lgp family. J. Biol. Chem. 268 13 (1993) 9661-9666
48. Rabinowitz S., Horstmann H., Gordon S., and Griffiths G. Immunocytochemical characterization of the endocytic and phagolysosomal compartments in peritoneal macrophages. J. Cell Biol. 116 1 (1992) 95-112
49. Rabinowitz S.S., and Gordon S. Macrosialin, a macrophage-restricted membrane sialoprotein differentially glycosylated in response to inflammatory stimuli. J. Exp. Med. 174 4 (1991) 827-836
50. Breel M., Mebius R.E., and Kraal G. Dendritic cells of the mouse recognized by 2 monoclonal-antibodies. Eur. J. Immunol. 17 11 (1987) 1555-1559
51. Hawiger D., Inaba K., Dorsett Y., Guo M., Mahnke K., Rivera M., Ravetch J.V., Steinman R.M., and Nussenzweig M.C. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194 6 (2001) 769-779
52. Inaba K., Swiggard W.J., Inaba M., Meltzer J., Mirza A., Sasagawa T., Nussenzweig M.C., and Steinman R.M. Tissue distribution of the Dec-205 protein that is detected by the monoclonal-antibody Nldc-145: 1. Expression on dendritic cells and other subsets of mouse leukocytes. Cell. Immunol. 163 1 (1995) 148-156
53. Jiang W.P., Swiggard W.J., Heufler C., Peng M., Mirza A., Steinman R.M., and Nussenzweig M.C. The Receptor Dec-205 expressed by dendritic cells and thymic epithelial-cells is involved in antigen-processing. Nature 375 6527 (1995) 151-155
54. Jiang W.P., Swiggard W.J., Mirza A., Peng M., Steinman R.M., and Nussenzweig M.C. Molecular characterization of a 205-kD protein that is abundant on dendritic cells and identified with the Nldc-145 monoclonal-antibody. J. Cell. Biochem. (1995) 20
55. Kraal G., Breel M., Janse M., and Bruin G. Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal-antibody. J. Exp. Med. 163 4 (1986) 981-997
56. Mahnke K., Guo M., Lee S., Sepulveda H., Swain S.L., Nussenzweig M., and Steinman R.M. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J. Cell Biol. 151 3 (2000) 673-683
57. Tabata Y., and Ikada Y. Phagocytosis of polymer microspheres by macrophages. Adv. Polym. Sci. 94 (1990) 107-141